Medical AI is artificial intelligence applied to clinical workflows — diagnostic imaging interpretation, ambient clinical documentation, predictive risk modeling embedded in the EHR, precision medicine decision support, and autonomous screening tools authorized by the FDA for deployment at the point of care. The category has moved past pilot and into enterprise procurement at every major U.S. Health system, and the FDA’s public registry now lists more than 1,000 AI/ML-enabled medical devices with the count roughly doubling every two years.
This archive collects 210 Digital Marketing’s coverage of Medical AI — the companies building it (Abridge, Aidoc, Viz.ai, Annalise.ai, PathAI, Paige.AI, Tempus AI, Isomorphic Labs, Insilico Medicine), the regulators shaping it (FDA, HHS Office for Civil Rights, ONC, CMS), and the health systems deploying it (Kaiser Permanente, Cleveland Clinic, Mount Sinai, Mayo Clinic, the VA). Articles cover FDA authorization pathways, peer-reviewed evidence, HIPAA business-associate requirements, local validation playbooks, and the governance discipline that separates compounding organizational advantage from stalled pilots.
If you lead a health system scoping where to invest, a payer evaluating Medical AI coverage policy, or a clinician trying to separate signal from vendor marketing, this tag archive is the starting point. Every piece here is filtered for operator-grade signal — peer-reviewed where clinical, FDA-authorized where regulatory, and grounded in deployed outcomes rather than demo-day benchmarks.
Recent Comments